- Home
- CHR vs TPST Comparison
CHR vs TPST Comparison
Compare CHR & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- TPST
- Stock Information
- Founded
- CHR 2016
- TPST 2011
- Country
- CHR China
- TPST United States
- Employees
- CHR N/A
- TPST N/A
- Industry
- CHR EDP Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- TPST Health Care
- Exchange
- CHR Nasdaq
- TPST Nasdaq
- Market Cap
- CHR 24.4M
- TPST 27.2M
- IPO Year
- CHR N/A
- TPST N/A
- Fundamental
- Price
- CHR $2.67
- TPST $0.97
- Analyst Decision
- CHR
- TPST Strong Buy
- Analyst Count
- CHR 0
- TPST 4
- Target Price
- CHR N/A
- TPST $20.00
- AVG Volume (30 Days)
- CHR 6.4K
- TPST 3.3M
- Earning Date
- CHR 07-31-2024
- TPST 11-12-2024
- Dividend Yield
- CHR N/A
- TPST N/A
- EPS Growth
- CHR N/A
- TPST N/A
- EPS
- CHR 3.44
- TPST N/A
- Revenue
- CHR $155,947,000.00
- TPST N/A
- Revenue This Year
- CHR N/A
- TPST N/A
- Revenue Next Year
- CHR N/A
- TPST N/A
- P/E Ratio
- CHR $0.79
- TPST N/A
- Revenue Growth
- CHR 0.88
- TPST N/A
- 52 Week Low
- CHR $2.18
- TPST $0.86
- 52 Week High
- CHR $3.90
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- CHR 45.02
- TPST 42.46
- Support Level
- CHR $2.67
- TPST $0.94
- Resistance Level
- CHR $2.86
- TPST $1.16
- Average True Range (ATR)
- CHR 0.10
- TPST 0.09
- MACD
- CHR -0.03
- TPST 0.01
- Stochastic Oscillator
- CHR 28.57
- TPST 39.34
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.